英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:

overeat    音标拼音: ['ovɚ,it]
vt. (使)吃过量

(使)吃过量

overeat
v 1: overeat or eat immodestly; make a pig of oneself; "She
stuffed herself at the dinner"; "The kids binged on ice
cream" [synonym: {gorge}, {ingurgitate}, {overindulge}, {glut},
{englut}, {stuff}, {engorge}, {overgorge}, {overeat},
{gormandize}, {gormandise}, {gourmandize}, {binge}, {pig
out}, {satiate}, {scarf out}]


请选择你想看的字典辞典:
单词字典翻译
Overeat查看 Overeat 在百度字典中的解释百度英翻中〔查看〕
Overeat查看 Overeat 在Google字典中的解释Google英翻中〔查看〕
Overeat查看 Overeat 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • ZORYVE® (roflumilast) | Official Patient Website
    ZORYVE cream 0 05% is a prescription medicine used on the skin (topical) to treat mild to moderate eczema (atopic dermatitis) in children 2 to 5 years of age It is not known if ZORYVE cream 0 05% is safe and effective in children with mild to moderate eczema (atopic dermatitis) under 2 years of age and 6 years of age and older
  • Zoryve: Uses, Dosage, Side Effects Warnings - Drugs. com
    Zoryve cream is used to treat plaque psoriasis and atopic dermatitis, and Zoryve foam is used for seborrheic dermatitis and plaque psoriasis Includes Zoryve side effects, dose, directions, and indications
  • Roflumilast in Dermatology: A Newer Phosphodiesterase-4 Inhibitor
    Roflumilast is approximately 25–300 times more potent than apremilast and crisaborole and has a much greater affinity to block PDE-4 [5] Topical roflumilast 0 3% cream was approved by the US FDA for the treatment of plaque psoriasis in July 2022 [6]
  • Roflumilast: Uses, Application, and Side-effects — DermNet
    Roflumilast is a phosphodiesterase-4 (PDE4) inhibitor used for the treatment of COPD and plaque psoriasis Topical roflumilast 0 3% cream (Zorvye™) was approved by the FDA in 2022 for the treatment of plaque psoriasis in patients aged 12 years and older
  • Roflumilast (topical application route) - Side effects dosage
    Description Roflumilast topical cream is used to treat plaque psoriasis, which is a form of skin disease with red patches and white scales that do not go away It is also used to treat mild to moderate atopic dermatitis Roflumilast topical foam is used to treat seborrheic dermatitis and plaque psoriasis of the scalp and body This medicine is available only with your doctor's prescription
  • Roflumilast Cream, 0. 15%, for Atopic Dermatitis in Adults and Children
    Two randomized clinical trials evaluate the efficacy and safety of once-daily roflumilast cream, 0 15%, vs vehicle cream in patients with atopic dermatitis
  • ZORYVE® (roflumilast) Cream 0. 15% 0. 05% | Official HCP Website
    Simpson E, Boguniewicz M, Eichenfield L, et al Pooled efficacy, patient-reported outcomes, and safety of roflumilast cream 0 15% from the INTEGUMENT-1 and INTEGUMENT-2 phase 3 clinical trials of adults and children with atopic dermatitis Poster presented at: American Academy of Dermatology Annual Meeting; March 8–12, 2024; San Diego, CA 6
  • Zoryve (Roflumilast): Uses, Side Effects, Dosage More - GoodRx
    Zoryve (roflumilast) is a cream and foam that's approved for treating certain skin conditions in adults and children Both can be used for plaque psoriasis The cream is also used for atopic dermatitis (eczema), and the foam can also be used for seborrheic dermatitis Zoryve (roflumilast) is a phosphodiesterase 4 (PDE4) inhibitor It works to lessen inflammation on the skin You apply Zoryve
  • Roflumilast Therapeutic Cheat Sheet - Next Steps in Dermatology
    Roflumilast is a non-steroidal topical cream that was FDA approved for the treatment of plaque psoriasis in 2022 1 Roflumilast selectively inhibits phosphodiesterase-4 (PDE-4), which is an enzyme that mediates inflammatory responses and has been shown to play a role in several dermatologic diseases 2 Prior to topical roflumilast, oral PDE-4 inhibitors have been investigated across a wide
  • ZORYVE (roflumilast) cream - Arcutis Biotherapeutics
    Our commitment to solving today’s biggest medical dermatology challenges doesn’t stop at bringing new treatment options There’s more to our Arcutis DNA It’s why we believe in responsible pricing and helping patients get access to our products through ZORYVE Direct and our commercial co-pay program, the ZORYVE Direct Savings Program, as well as Arcutis Cares





中文字典-英文字典  2005-2009